Acta Vet. Brno 2021, 90: 383-390
https://doi.org/10.2754/avb202190040383
Pharmacokinetics of toltrazuril and its metabolites toltrazuril sulphoxide and toltrazuril sulphone in pregnant and non-pregnant goats
References
1. 2020: Pharmacokinetics of toltrazuril and its metabolites in pregnant and non-pregnant ewes and determination of their concentrations in milk, allantoic fluid, and newborn plasma. J Vet Pharmacol Ther 43: 339-346
< RF, Abu‐Basha EA, Ababneh MM, Bani Ismail Z, Idkaidek NM https://doi.org/10.1111/jvp.12845>
2. 1993: Stereoselective S-oxygenation of an aryl-trifluoromethyl sulfoxide to the corresponding sulfone by rat liver cytochromes P450. Biochem Pharmacol 46: 2337-2341
< E, Buronfosse T, Moroni P, Delatour P, Riviere JL https://doi.org/10.1016/0006-2952(93)90626-8>
3. 2009: Synthesis and detection of toltrazuril sulfone and its pharmacokinetics in horses following administration in dimethylsulfoxide. J Vet Pharmacol Ther 32: 368-378
< L, Karpiesiuk W, Lehner AF, Hughes C, Granstrom DE, Tobin T https://doi.org/10.1111/j.1365-2885.2008.01053.x>
4. European Agency for the Evaluation of European Medicines Agency (EMEA). Committee for Veterinary Products/The European Agency for the Evaluation of Medicinal Products. Toltrazuril (Extension to Pigs)—Summary Report, EMEA/MRL/620/99-FINAL, 1999. Available at https://www.ema.europa.eu/en/documents/mrl-report/toltrazuril-extension-pigs-summary-report-2-committee-veterinary-medicinal-products_en.pdf
5. European Agency for the evaluation of European Medicines Agency (EMEA). Committee for Veterinary Products/The European Agency for the Evaluation of Medicinal Products. Toltrazuril (Extension to Pig)—Summary Report, EMEA/MRL/907/00-FINAL, 2000
6. 1989: Possible mode of action of toltrazuril: studies on two Eimeria species and mammalian and Ascaris suum enzymes. Parasitol Res 76: 8-12
< A, Haberkorn A https://doi.org/10.1007/BF00931064>
7. 2010: Pharmacokinetics and improved bioavailability of toltrazuril after oral administration to rabbits. J Vet Pharmacol Ther 33: 503-506
< L, Liu C, Shang C, Yang X, Yang J https://doi.org/10.1111/j.1365-2885.2010.01163.x>
8. 1988: The effect of pregnancy on drug pharmacokinetics. Med J Aust 149: 675-677
< W S, Bochner F https://doi.org/10.5694/j.1326-5377.1988.tb120820.x>
9. 2010: Plasma disposition of toltrazuril and its metabolites, toltrazuril sulfoxide and toltrazuril sulfone, in rabbits after oral administration. Vet Parasitol 169: 51-56
< MS, Lim JH, Hwang YH, Park BK, Song IB, Yun HI https://doi.org/10.1016/j.vetpar.2009.12.011>
10. 2013: Pharmacokinetics and metabolism of toltrazuril and its major metabolites after oral administration in broilers. The J Poult Sci 50: 257-261
< MS, Park BK, Hwang YH, Song IB, Kim TW, Cho JH, Ham SH, Lim JH, Yun HI https://doi.org/10.2141/jpsa.0120050>
11. 2013: In-vivo efficacy of toltrazuril on experimentally induced Toxoplasma gondii tissue cysts in lambs: a novel strategy for prevention of human exposure to meat-borne toxoplasmosis. Res Vet Sci 94: 269-276
< O, Yildiz K, Ocal N, Freyre A, Deniz A, Karahan S, Atmaca HT, Gokpinar S, Dincel GC, Uzunalioğlu T, Terzi OS https://doi.org/10.1016/j.rvsc.2012.08.001>
12. 2010: Pharmacokinetics of toltrazuril and its metabolites, toltrazuril sulfoxide and toltrazuril sulfone, after a single oral administration to pigs. J Vet Med Sci 72: 1085-1087
< JH, Kim MS, Hwang YH, Song IB, Park BK, Yun HI https://doi.org/10.1292/jvms.09-0524>
13. 1997: Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 33: 328-343
< R, Lalkin A, Koren G https://doi.org/10.2165/00003088-199733050-00002>
14. 1987: The pharmacokinetics of antiarrythmic agents in pregnancy and lactation. Clin Pharmacokinet 12: 253-291
< GM, Steinberg I, Lien E, Harrison C, Elkayan U https://doi.org/10.2165/00003088-198712040-00002>
15. 2007: Efficacy of various anticoccidials against experimental porcine neonatal isosporosis. Parasitol Res 100: 401-411
< HC, Mundt-Wüstenberg S, Daugschies A, Joachim A https://doi.org/10.1007/s00436-006-0314-9>
16. 2008: Pharmacokinetics of ivermectin in pregnant and nonpregnant sheep. J Vet Pharmacol Ther 31: 71-76
< R, Palma C, Nunez MJ, Cox J, Arboix M https://doi.org/10.1111/j.1365-2885.2007.00926.x>
17. 2015: Activity of several kinds of drugs against Neospora caninum. Parasitol Int 64: 597-602
< W, Wang H, Shan D, Li B, Liu J, Liu Q https://doi.org/10.1016/j.parint.2015.08.002>
18. 1988: Metoclopramide pharmacokinetics in pregnant and nonpregnant sheep. J Pharmacol Sci 77: 373-379
< KW, Axelson JE, Gruber NC, McErlane BA, McMorland, GH, Rurak DW https://doi.org/10.1002/jps.2600770502>
19. 2018: Review of triazine antiprotozoal drugs used in veterinary medicine. J Vet Pharmacol Ther 41: 184-194
< ML, Elazab ST, Hsu WH https://doi.org/10.1111/jvp.12450>
20. 1997: Preliminary pharmacokinetics of diclazuril and toltrazuril in the horse. Am Assoc Equine Pract 43: 15-16
T, Dirikolu L, Harkins JD, Garnstrom DE, Carter W, Lehner F, Rees WA
21. 2014: SPE–UPLC–UV method for the determination of Toltrazuril and its two metabolite residues in chicken and porcine tissues. Chromatographia 77: 1705-1712
< J, Lifang Z, Chong Z, Xiao Z, Feiqun, X https://doi.org/10.1007/s10337-014-2759-9>